scholarly journals Evolution of CT patterns in novel coronavirus (2019-nCoV) pneumonia in relation to clinical and laboratory data

2021 ◽  
Vol 12 (2) ◽  
pp. 49-58
Author(s):  
А. А. Oganesyan ◽  
I. V. Shrainer ◽  
V. N. Vinogradov ◽  
E. S. Pershina ◽  
E. G. Koshelev ◽  
...  
Keyword(s):  
Prognostic Value ◽  
Patient Management ◽  
Dynamic Change ◽  
Laboratory Data ◽  
Good Prognosis ◽  
Organizing Pneumonia ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Novel Coronavirus ◽  
Ct Studies

Introduction. The CT patterns of coronavirus pneumonia are clear and represent certain pathomorphosis at the period of coronavirus pandemic. However, there are a lot of questions about influence of CT-patterns and their dynamic change on a disease’s severity. The aim of the study. To evaluate the dynamics of pulmonary CT changes of novel coronavirus (2019-nCoV) pneumonia in relation to clinical and laboratory data. Materials and methods. CT studies in dynamics of 108 patients with a of novel coronavirus (2019-nCoV) pneumonia were analyzed. The first CT study was performed on admission (6,7±4,1 days of the disease), the first control CT on 11,1±4,9 days of the disease, and the second CT control was performed on 16,7±5,6 days of the disease. Results. The volume of the lesion and the predominant CT symptom at admission did not affect the prognosis. However, changes in the repeated CT study had a high prognostic value. Thus, the occurrence of a pattern of organizing pneumonia during repeated study is associated with a good prognosis, while an increase in the zones of «crazy paving» and a larger volume of damage are unfavorable prognostic signs. An increase in the volume of changes in the type of ground glass and «crazy paving» correlated with increased levels of C-reactive protein, lactate dehydrogenase, and lymphopenia. Conclusion. Data from CT studies in dynamics for novel coronavirus (2019-nCoV) pneumonia have a prognostic value and, in combination with clinical and laboratory data, can influence decision-making on patient management.

scholarly journals EXPRESS: Serum biomarkers for prediction of mortality in patients with COVID-19

2021 ◽  
pp. 000456322110142
Author(s):  
Rohit S Loomba ◽  
Enrique G Villarreal ◽  
Juan S Farias ◽  
Gaurav Aggarwal ◽  
Saurabh Aggarwal ◽  
...  
Keyword(s):  
High Sensitivity ◽  
Hepatic Function ◽  
Pooled Analysis ◽  
Cardiac Biomarkers ◽  
Limited Information ◽  
C Reactive Protein ◽  
Acute Phase Reactants ◽  
Reactive Protein ◽  
Prediction Of Mortality ◽  
Novel Coronavirus

Background There is limited information regarding the role of biomarker levels at predicting mortality in patients with the novel coronavirus pandemic (Covid-19). The purpose of this study is to determine the differences in serum biomarker levels in adults with Covid-19 who survived hospitalization from those who did not. Methods A comprehensive search was completed on PubMed, EMBASE, and Cochrane libraries to identify studies of interest. Endpoints of interest were blood counts, hepatic function test, acute phase reactants, cytokines and cardiac biomarkers. Results A total of 10 studies with 1,584 patients were included in the pooled analyses. Biomarkers that were noted to be significantly higher in those who died from Covid-19 (coronavirus disease 2019) included: white blood cell count, neutrophil count, C-reactive protein, high sensitivity C-reactive protein, procalcitonin, ferritin, D-dimer, interleukins 6, lactate dehydrogenase, creatine kinase, prothrombin time, aspartate aminotransferase, alanine aminotransferase, total bilirubin, and creatinine. Lymphocyte count, platelet count, and albumin were significantly lower in patients who died. Conclusion This pooled analysis of 10 studies including 1,584 patients identified significant differences in biomarkers on admission in patients who survived from those who did not. Further research is needed to develop risk stratification models to help with judicious use of limited healthcare resources.

Prognostic value of C-reactive protein in parapneumonic effusions

Respirology ◽  
2012 ◽  
Vol 17 (2) ◽  
pp. 308-314 ◽  
Author(s):  
VASILEIOS SKOURAS ◽  
EUAGGELOS BOULTADAKIS ◽  
DIMITRIOS NIKOULIS ◽  
VLASIS POLYCHRONOPOULOS ◽  
ZOE DANIIL ◽  
...  
Keyword(s):  
Prognostic Value ◽  
C Reactive Protein ◽  
Reactive Protein

The Prognostic Value of Different Levels of Cortisol and High-sensitivity C-reactive Protein in Early Acute Pancreatitis

2021 ◽  
Author(s):  
Hanan Sharaf El-Deen Mohammed ◽  
Haidi Karam-Allah Ramadan ◽  
Reham I El-Mahdy ◽  
Entsar H Ahmed ◽  
Amal Hosni ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Prognostic Value ◽  
High Sensitivity ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Different Levels

scholarly journals Chondrosternal Arthritis in Infant: An Unusual Entity

2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Athina Nikolarakou ◽  
Dana Dumitriu ◽  
Pierre-Louis Docquier
Keyword(s):  
Clinical Symptoms ◽  
Therapeutic Option ◽  
White Blood Cells ◽  
Laboratory Data ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
History Of ◽  
Local Tenderness ◽  
Wait And See

Primary arthritis of chondrosternal joint is very rare and occurs in infants less than 18 months of age. Presentation is most often subacute but may be acute. Child presents with a parasternal mass with history of fever and/or local signs of infection. Clinical symptoms vary from a painless noninflammatory to a painful mass with local tenderness and swelling, while fever may be absent. Laboratory data show low or marginally raised levels of white blood cells and C-reactive protein, reflecting, respectively, the subacute or acute character of the infection. It is a self-limiting affection due to the adequate immune response of the patient. Evolution is generally good without antibiotherapy with a progressive spontaneous healing. A wait-and-see approach with close follow-up in the first weeks is the best therapeutic option.

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1994 ◽  
Vol 331 (7) ◽  
pp. 417-424 ◽  
Author(s):  
Giovanna Liuzzo ◽  
Luigi M. Biasucci ◽  
J. Ruth Gallimore ◽  
Rita L. Grillo ◽  
Antonio G. Rebuzzi ◽  
...  
Keyword(s):  
Unstable Angina ◽  
Prognostic Value ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Amyloid A ◽  
Serum Amyloid A Protein

scholarly journals Retrospective analysis of the clinical features of outpatients with novel coronavirus in areas outside Wuhan, China

2020 ◽  
Author(s):  
Yong-Tao Li ◽  
Mei-Lian Peng ◽  
Jia-dan Fu ◽  
Li Liu ◽  
Yong-zheng Guo ◽  
...  
Keyword(s):  
Pathogen Detection ◽  
Clinical Performance ◽  
The Novel ◽  
C Reactive Protein ◽  
Early Screening ◽  
Reactive Protein ◽  
Ct Findings ◽  
Epidemic Area ◽  
Novel Coronavirus ◽  
Lung Ct

Abstract Objective: The novel coronavirus pneumonia (COVID-19) has spread rapidly across the globe with the movement of people. How to diagnose COVID-19 quickly and accurately is a concern for all. We retrospectively assessed the clinical characteristics of patients with COVID-19 detected by outpatient screening in areas outside Wuhan, China, to guide early screening outside the epidemic area, to isolate and treat COVID-19-positive patients, and to control the spread of this virus in the region.Results: Among the 213 patients treated in the fever clinic of our hospital, 41 tested positive for novel coronavirus (2019-nCoV) and 172 were negative. Among the positive patients, 13 (31.7%) of the patients had been to Wuhan, while 28 (68.3%) had not been to Wuhan. There were 4 cases of clustering occurrence. The main symptoms exhibited by COVID-19-positive patients were fever (87.8%), cough (68.3%), and expectoration (34.1%). The C-reactive protein (CRP) levels were increased in 35 (85.3%) positive patients; the hydroxybutyrate dehydrogenase in the myocardial zymogram was increased in 22 positive patients (53.6%) and 38 negative patients (22.1%); computed tomography (CT) findings revealed lung lesions in all 41 positive patients (100%).Conclusion: We classified the patient population and analyzed the data to understand the early clinical performance of COVID-19. Our research illustrate that screening for COVID-19 outside Wuhan should focus on early symptoms such as fever and cough, in combination with lung CT findings, epidemiological history, and sputum pathogen detection to determine whether patients need further isolation.

scholarly journals Comparison laboratory data between children with Kawasaki Disease and COVID-19

2021 ◽  
Author(s):  
Xiaoping Liu ◽  
Ying-Hsien Huang ◽  
Yuh-Chyn Tsai ◽  
Shih-Feng Liu ◽  
Ho-Chang Kuo
Keyword(s):  
New York ◽  
Kawasaki Disease ◽  
Multiple Logistic Regression Analysis ◽  
Laboratory Data ◽  
Retrospective Chart Review ◽  
Reactive Protein ◽  
First Case ◽  
Neutrophil Percentage ◽  
Adults And Children ◽  
Novel Coronavirus

Abstract Background: The 2019 coronavirus disease (COVID-19) has been an emerging, rapidly evolving situation in China since late 2019 and has even become a worldwide pandemic. The first case of severe childhood novel coronavirus pneumonia in China was reported in March 2020 in Wuhan. The severity differs between adults and children, with lower death rates and decreased severity for individuals under the age of 20 years old. Increased cases of Kawasaki disease (KD) have been reported from New York City and some areas of Italy and the U.K., with almost a 6-10 times increase when compared with previous years. We conducted this article to compare characters and laboratory data between KD and COVID-19 in children. Methods: We obtained a total of 24 COVID-19 children from the literature review and 234 KD cases from our hospital via retrospective chart review. Results: We found that patients with KD had higher levels of white blood cell (WBC), platelet, neutrophil percentage, C-reactive protein (CRP), procalcitonin, Aspartate Aminotransferase (AST), and body temperature, while patients with COVID-19 had higher age, hemoglobin levels, and lymphocyte percentage. After performing multiple logistic regression analysis, we found that age, WBC, platelet, procalcitonin, and AST provide identical markers for distinguishing COVID-19 from KD in children. Conclusion: In this COVID-19 pandemic period, clinicians should pay attention to children with COVID-19 infection when high WBC, platelet, procalcitonin, and AST values are present in order to provide precision treatment with intravenous immunoglobulin (IVIG) for KD or multisystem inflammatory syndrome in children (MIS-C).

Sign in / Sign up

Export Citation Format

Share Document